Home wrinkle treatment wins FDA clearance
The FDA clears Cynosure's home anti-wrinkle device for over-the-counter sales.
Developed in conjunction with consumer goods maker Unilever (NYSE:UL), the as-yet-unnamed device was cleared for over-the-counter sales in the U.S.
"FDA clearance of this device marks a significant milestone in our alliance with Unilever to develop light-based devices for the consumer market," Cynosure president & CEO Michael Davin said in prepared remarks. "Our strategic partnership with Unilever blends our expertise in developing market leading light-based technology that emphasizes patient safety and clinical results, with Unilever's unparalleled innovation, branded marketing and distribution."